\-\ Texto\\:\\ \ \(0\)\
\-\ elevated\\ serum\\ calcium\\ and\\ parathyroid\\ hormone\\ levels\ \(2\)\
\-\ persistent\\ focal\\ increased\\ activity\\ in\\ the\\ inferior\\ region\\ adjacent\\ to\\ the\\ left\\ lower\\ pole\\ of\\ thyroid\ \(0\)\
\-\ hyperparathyroidism\\ \\-\\ parathyroid\\ adenoma\ \(0\)\
\-\ parathyroid\\ adenoma\ \(27\)\
\-\ thyroid\\ adenoma\ \(56\)\
\-\ 46\\ y\\/o\\ female\\ with\\ hypercalcemia\\ and\\ elevated\\ parathormone\\ level\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ parathyroid\\:\\ 0\\.5571325557428188\ \(0\)\
\-\ adenoma\\:\\ 0\\.4047289540339004\ \(0\)\
\-\ thyroid\\:\\ 0\\.2659711524309533\ \(0\)\
\-\ parathormone\\:\\ 0\\.2585893283206384\ \(0\)\
\-\ elevated\\:\\ 0\\.23071712286190854\ \(0\)\
\-\ hypercalcemia\\:\\ 0\\.19816571536206104\ \(0\)\
\-\ hormone\\:\\ 0\\.17230282181956377\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.16118763067168698\ \(0\)\
\-\ 46\\:\\ 0\\.15547169590938736\ \(0\)\
\-\ calcium\\:\\ 0\\.1528395976790828\ \(0\)\
\-\ serum\\:\\ 0\\.15174077725480986\ \(0\)\
\-\ pole\\:\\ 0\\.14747775191550822\ \(0\)\
\-\ levels\\:\\ 0\\.1341547821220153\ \(0\)\
\-\ persistent\\:\\ 0\\.13038052956439866\ \(0\)\
\-\ activity\\:\\ 0\\.12423736973797905\ \(0\)\
\-\ inferior\\:\\ 0\\.1151221875928705\ \(0\)\
\-\ adjacent\\:\\ 0\\.10968751454529374\ \(0\)\
\-\ level\\:\\ 0\\.10221781577196991\ \(0\)\
\-\ focal\\:\\ 0\\.10121890793669476\ \(0\)\
\-\ region\\:\\ 0\\.10121890793669476\ \(0\)\
\-\ increased\\:\\ 0\\.09150536324450571\ \(0\)\
\-\ lower\\:\\ 0\\.0864708808242442\ \(0\)\
\-\ female\\:\\ 0\\.08165577120721601\ \(0\)\
\-\ and\\:\\ 0\\.06993389691372286\ \(0\)\
\-\ the\\:\\ 0\\.06753047780558168\ \(0\)\
\-\ left\\:\\ 0\\.057724149344718444\ \(0\)\
\-\ to\\:\\ 0\\.042304313372493\ \(0\)\
\-\ in\\:\\ 0\\.042096091629688824\ \(0\)\
\-\ with\\:\\ 0\\.03313511411103185\ \(0\)\
\-\ of\\:\\ 0\\.0331153277106157\ \(0\)\
